EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

Shuangping Guo, Xia Li, Joseph Rohr, Yingmei Wang, Shirong Ma, Peng Chen, Zhe Wang

ABSTRACT

BACKGROUND: Enhancer of zest homolog 2 (EZH2), a histone 3 methyltransferase, is associated with aggressive behavior of many tumors and is a promising target of molecular therapy. METHODS: To better elucidate the relevance of EZH2 in breast cancer subtypes, we evaluated EZH2 expression in 226 invasive breast carcinomas with four distinct immunophenotypes and in association with clinicopathological features. RESULTS: Of these cases, 138 (61.1 %) were defined as EZH2-overexpressing with a multiplicative score > 3. EZH2 expression was inversely related to the status of ER and PR (Chi-square, p < 0.001), and it was significantly associated with HER2 positivity, high proliferative index, and high histologic grade (Chi-square, p < 0.05). ER-positive breast carcinoma with low proliferative index (Ki67 < 14 %) showed the lowest expression and triple-negative breast carcinoma showed the highest overexpression of EZH2, 18.5 % (10/54) versus 90.9 % (50/55) (Chi-square, p < 0.001). Intriguingly, 88 % (44/50) cases of grade 3 triple-negative breast carcinoma showed uniformly strong EZH2 expression with a multiplicative score of 9. The percentage of EZH2 overexpression in ER-positive breast carcinoma with a high proliferative index or HER2-positive cases were 61.2 and 74 %, respectively. Furthermore, EZH2 expression was significantly elevated in high-grade DCIS compared to benign lesions (90 % versus 0, p < 0.001). However, there is no association between EZH2 expression and the status of histone 3 lysine 27 trimethylation or other clinicopathologic features. CONCLUSION: In summary, triple-negative breast carcinoma showed the highest overexpression of EZH2. EZH2 overexpression is associated aggressive pathologic features including high nuclear grade, high proliferative index, and positivity of HER2 of breast carcinoma. More... »

PAGES

41

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13000-016-0491-5

DOI

http://dx.doi.org/10.1186/s13000-016-0491-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1012145202

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27113214


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Proliferation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enhancer of Zeste Homolog 2 Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ki-67 Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Grading", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Invasiveness", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polycomb Repressive Complex 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Predictive Value of Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, ErbB-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Triple Negative Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Up-Regulation", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Fourth Military Medical University", 
          "id": "https://www.grid.ac/institutes/grid.233520.5", 
          "name": [
            "Department of Pathology, Xi Jing Hospital, the Fourth Military Medical University, 710032, Xi\u2019an, Shaan Xi Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guo", 
        "givenName": "Shuangping", 
        "id": "sg:person.01242362136.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242362136.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fourth Military Medical University", 
          "id": "https://www.grid.ac/institutes/grid.233520.5", 
          "name": [
            "Department of Pathology, Xi Jing Hospital, the Fourth Military Medical University, 710032, Xi\u2019an, Shaan Xi Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Xia", 
        "id": "sg:person.0630461205.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630461205.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Nebraska Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.266813.8", 
          "name": [
            "Department of Pathology and Microbiology, University of Nebraska Medical Center, 68105, Omaha, NE, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rohr", 
        "givenName": "Joseph", 
        "id": "sg:person.0637150121.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637150121.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fourth Military Medical University", 
          "id": "https://www.grid.ac/institutes/grid.233520.5", 
          "name": [
            "Department of Pathology, Xi Jing Hospital, the Fourth Military Medical University, 710032, Xi\u2019an, Shaan Xi Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Yingmei", 
        "id": "sg:person.01202060376.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202060376.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fourth Military Medical University", 
          "id": "https://www.grid.ac/institutes/grid.233520.5", 
          "name": [
            "Department of Pathology, Xi Jing Hospital, the Fourth Military Medical University, 710032, Xi\u2019an, Shaan Xi Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ma", 
        "givenName": "Shirong", 
        "id": "sg:person.01103252766.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103252766.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fourth Military Medical University", 
          "id": "https://www.grid.ac/institutes/grid.233520.5", 
          "name": [
            "Department of Pathology, Xi Jing Hospital, the Fourth Military Medical University, 710032, Xi\u2019an, Shaan Xi Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Peng", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fourth Military Medical University", 
          "id": "https://www.grid.ac/institutes/grid.233520.5", 
          "name": [
            "Department of Pathology, Xi Jing Hospital, the Fourth Military Medical University, 710032, Xi\u2019an, Shaan Xi Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Zhe", 
        "id": "sg:person.01067625121.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067625121.42"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1073/pnas.1308953111", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000483367"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.1933744100", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006013665"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-05-1533", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006433730"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncomms6987", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007923439", 
          "https://doi.org/10.1038/ncomms6987"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-05-4300", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010802411"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2217/epi.14.59", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010854839"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.molonc.2012.06.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011420580"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2012.390", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011568592", 
          "https://doi.org/10.1038/onc.2012.390"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.25.6529", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016721540"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.humpath.2011.12.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017914229"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-06-2384", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018316116"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2008.433", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019798988", 
          "https://doi.org/10.1038/onc.2008.433"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-10-1199", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022542303"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-11-3546", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022967334"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5858/arpa.2013-0953-sa", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023063099"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/mcb.00426-13", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026714846"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/emboj/cdg542", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029576413"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2011.118", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033534564", 
          "https://doi.org/10.1038/onc.2011.118"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdu391", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035440462"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.22381", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036147682"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4161/epi.24532", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042356293"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ott.s67673", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044115872"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/00313020802563510", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045011485"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/00313020802563510", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045011485"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.01.5180", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046338079"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-06-3045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048367977"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/pat.0b013e3283534bcb", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060343612"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/pat.0b013e3283534bcb", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060343612"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/pat.0b013e3283534bcb", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060343612"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/1871520615666150129211901", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069219098"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4161/cbt.27306", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072293046"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4161/cbt.27306", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072293046"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-12", 
    "datePublishedReg": "2016-12-01", 
    "description": "BACKGROUND: Enhancer of zest homolog 2 (EZH2), a histone 3 methyltransferase, is associated with aggressive behavior of many tumors and is a promising target of molecular therapy.\nMETHODS: To better elucidate the relevance of EZH2 in breast cancer subtypes, we evaluated EZH2 expression in 226 invasive breast carcinomas with four distinct immunophenotypes and in association with clinicopathological features.\nRESULTS: Of these cases, 138 (61.1\u00a0%) were defined as EZH2-overexpressing with a multiplicative score\u2009>\u20093. EZH2 expression was inversely related to the status of ER and PR (Chi-square, p\u2009<\u20090.001), and it was significantly associated with HER2 positivity, high proliferative index, and high histologic grade (Chi-square, p\u2009<\u20090.05). ER-positive breast carcinoma with low proliferative index (Ki67\u2009<\u200914\u00a0%) showed the lowest expression and triple-negative breast carcinoma showed the highest overexpression of EZH2, 18.5\u00a0% (10/54) versus 90.9\u00a0% (50/55) (Chi-square, p\u2009<\u20090.001). Intriguingly, 88\u00a0% (44/50) cases of grade 3 triple-negative breast carcinoma showed uniformly strong EZH2 expression with a multiplicative score of 9. The percentage of EZH2 overexpression in ER-positive breast carcinoma with a high proliferative index or HER2-positive cases were 61.2 and 74\u00a0%, respectively. Furthermore, EZH2 expression was significantly elevated in high-grade DCIS compared to benign lesions (90\u00a0% versus 0, p\u2009<\u20090.001). However, there is no association between EZH2 expression and the status of histone 3 lysine 27 trimethylation or other clinicopathologic features.\nCONCLUSION: In summary, triple-negative breast carcinoma showed the highest overexpression of EZH2. EZH2 overexpression is associated aggressive pathologic features including high nuclear grade, high proliferative index, and positivity of HER2 of breast carcinoma.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13000-016-0491-5", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1327435", 
        "issn": [
          "2364-4893", 
          "1746-1596"
        ], 
        "name": "Diagnostic Pathology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "name": "EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features", 
    "pagination": "41", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "39dcfde2c02192883b8eb483d491df7a9a59de9f97fd96b641475b4ea422d08a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27113214"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101251558"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13000-016-0491-5"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1012145202"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13000-016-0491-5", 
      "https://app.dimensions.ai/details/publication/pub.1012145202"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:51", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89789_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs13000-016-0491-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13000-016-0491-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13000-016-0491-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13000-016-0491-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13000-016-0491-5'


 

This table displays all metadata directly associated to this object as RDF triples.

285 TRIPLES      21 PREDICATES      78 URIs      42 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13000-016-0491-5 schema:about N00d96d5472b044ca9f314a35092fbf93
2 N1fcd1e164d77463e88526ba64b662e6f
3 N38b9d8356f1a42378f3a56d4fba4914e
4 N4f7d07b9646b44588fcfc13004bfb64a
5 N59bc47fbf691402ab39170d78d4e47e0
6 N695b3a4818064961a05f2a18d112429a
7 N6d02ae20e3f947ad8bed3f2c0d60840a
8 N6fab1836c38941d1aca48c2d7672330f
9 N715b3befdce242e4b0237bd0b90bd1f1
10 N7204368dca8d4f518c2d6a903c1c41c1
11 N7aaa5a003d1841f1a706ac9ae2825905
12 N8aa8a93d4dab4148b423022e2b4ddc86
13 Naee48dc221e8494aa079d4ad9cad7d80
14 Nb0e854f102e949888833145806fbbf20
15 Ncd3e7c7dad6d47469cb63aea004a16e8
16 Nd0fc61569582451ead430803ee568412
17 Nd4aaadab747e443586028de542e64357
18 Ne92dd8face5c46278ee7471f874f8cce
19 Nef2b0261c5704f59814910f17e6682fd
20 Nf11900d2e4cf47349ac7521bea77e96d
21 Nf3e02413f93746f78ba95fa4972216c8
22 anzsrc-for:11
23 anzsrc-for:1112
24 schema:author Nd1ef705e52b94b06b99e2ed3ddc94cab
25 schema:citation sg:pub.10.1038/ncomms6987
26 sg:pub.10.1038/onc.2008.433
27 sg:pub.10.1038/onc.2011.118
28 sg:pub.10.1038/onc.2012.390
29 https://doi.org/10.1002/cncr.22381
30 https://doi.org/10.1016/j.humpath.2011.12.004
31 https://doi.org/10.1016/j.molonc.2012.06.002
32 https://doi.org/10.1073/pnas.1308953111
33 https://doi.org/10.1073/pnas.1933744100
34 https://doi.org/10.1080/00313020802563510
35 https://doi.org/10.1093/annonc/mdu391
36 https://doi.org/10.1093/emboj/cdg542
37 https://doi.org/10.1097/pat.0b013e3283534bcb
38 https://doi.org/10.1128/mcb.00426-13
39 https://doi.org/10.1158/0008-5472.can-05-4300
40 https://doi.org/10.1158/0008-5472.can-06-2384
41 https://doi.org/10.1158/0008-5472.can-10-1199
42 https://doi.org/10.1158/0008-5472.can-11-3546
43 https://doi.org/10.1158/1078-0432.ccr-05-1533
44 https://doi.org/10.1158/1078-0432.ccr-06-3045
45 https://doi.org/10.1200/jco.2005.01.5180
46 https://doi.org/10.1200/jco.2009.25.6529
47 https://doi.org/10.2147/ott.s67673
48 https://doi.org/10.2174/1871520615666150129211901
49 https://doi.org/10.2217/epi.14.59
50 https://doi.org/10.4161/cbt.27306
51 https://doi.org/10.4161/epi.24532
52 https://doi.org/10.5858/arpa.2013-0953-sa
53 schema:datePublished 2016-12
54 schema:datePublishedReg 2016-12-01
55 schema:description BACKGROUND: Enhancer of zest homolog 2 (EZH2), a histone 3 methyltransferase, is associated with aggressive behavior of many tumors and is a promising target of molecular therapy. METHODS: To better elucidate the relevance of EZH2 in breast cancer subtypes, we evaluated EZH2 expression in 226 invasive breast carcinomas with four distinct immunophenotypes and in association with clinicopathological features. RESULTS: Of these cases, 138 (61.1 %) were defined as EZH2-overexpressing with a multiplicative score > 3. EZH2 expression was inversely related to the status of ER and PR (Chi-square, p < 0.001), and it was significantly associated with HER2 positivity, high proliferative index, and high histologic grade (Chi-square, p < 0.05). ER-positive breast carcinoma with low proliferative index (Ki67 < 14 %) showed the lowest expression and triple-negative breast carcinoma showed the highest overexpression of EZH2, 18.5 % (10/54) versus 90.9 % (50/55) (Chi-square, p < 0.001). Intriguingly, 88 % (44/50) cases of grade 3 triple-negative breast carcinoma showed uniformly strong EZH2 expression with a multiplicative score of 9. The percentage of EZH2 overexpression in ER-positive breast carcinoma with a high proliferative index or HER2-positive cases were 61.2 and 74 %, respectively. Furthermore, EZH2 expression was significantly elevated in high-grade DCIS compared to benign lesions (90 % versus 0, p < 0.001). However, there is no association between EZH2 expression and the status of histone 3 lysine 27 trimethylation or other clinicopathologic features. CONCLUSION: In summary, triple-negative breast carcinoma showed the highest overexpression of EZH2. EZH2 overexpression is associated aggressive pathologic features including high nuclear grade, high proliferative index, and positivity of HER2 of breast carcinoma.
56 schema:genre research_article
57 schema:inLanguage en
58 schema:isAccessibleForFree true
59 schema:isPartOf Nc95f9349a26d4e838498a00f1419d41f
60 Nca3a7d92a5974584b4971d07472f5dda
61 sg:journal.1327435
62 schema:name EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features
63 schema:pagination 41
64 schema:productId N940d4e65b73b4ae7a5177d49f372703f
65 Na5a5032a632043778296f333f8e747d1
66 Nc0b9189d45a844b086e79c81ab1a9994
67 Nc6c54c46922a4ca584daf94060fff1c7
68 Nf39181cd81a049f6ac62397666657db6
69 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012145202
70 https://doi.org/10.1186/s13000-016-0491-5
71 schema:sdDatePublished 2019-04-11T09:51
72 schema:sdLicense https://scigraph.springernature.com/explorer/license/
73 schema:sdPublisher N179108354e234f2982a37f5818cc7a41
74 schema:url https://link.springer.com/10.1186%2Fs13000-016-0491-5
75 sgo:license sg:explorer/license/
76 sgo:sdDataset articles
77 rdf:type schema:ScholarlyArticle
78 N00d96d5472b044ca9f314a35092fbf93 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Phenotype
80 rdf:type schema:DefinedTerm
81 N179108354e234f2982a37f5818cc7a41 schema:name Springer Nature - SN SciGraph project
82 rdf:type schema:Organization
83 N1fcd1e164d77463e88526ba64b662e6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Receptor, ErbB-2
85 rdf:type schema:DefinedTerm
86 N38b9d8356f1a42378f3a56d4fba4914e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Enhancer of Zeste Homolog 2 Protein
88 rdf:type schema:DefinedTerm
89 N3a1bcf1f0c094d3cb2cdf0632fb41d69 schema:affiliation https://www.grid.ac/institutes/grid.233520.5
90 schema:familyName Chen
91 schema:givenName Peng
92 rdf:type schema:Person
93 N4f7d07b9646b44588fcfc13004bfb64a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Carcinoma
95 rdf:type schema:DefinedTerm
96 N59bc47fbf691402ab39170d78d4e47e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Middle Aged
98 rdf:type schema:DefinedTerm
99 N695b3a4818064961a05f2a18d112429a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Aged, 80 and over
101 rdf:type schema:DefinedTerm
102 N6c25b68220bc4eb88c80441f8e9f920f rdf:first sg:person.01202060376.90
103 rdf:rest Nb056f182cbb24ab89933291122d7bc19
104 N6d02ae20e3f947ad8bed3f2c0d60840a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Ki-67 Antigen
106 rdf:type schema:DefinedTerm
107 N6fab1836c38941d1aca48c2d7672330f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Neoplasm Invasiveness
109 rdf:type schema:DefinedTerm
110 N715b3befdce242e4b0237bd0b90bd1f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Polycomb Repressive Complex 2
112 rdf:type schema:DefinedTerm
113 N7204368dca8d4f518c2d6a903c1c41c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Neoplasm Grading
115 rdf:type schema:DefinedTerm
116 N7aaa5a003d1841f1a706ac9ae2825905 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Triple Negative Breast Neoplasms
118 rdf:type schema:DefinedTerm
119 N8a448165ede34fd0a7697b9231009556 rdf:first N3a1bcf1f0c094d3cb2cdf0632fb41d69
120 rdf:rest N932f5a45f0e84622978ff68f81c520a1
121 N8aa8a93d4dab4148b423022e2b4ddc86 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Humans
123 rdf:type schema:DefinedTerm
124 N932f5a45f0e84622978ff68f81c520a1 rdf:first sg:person.01067625121.42
125 rdf:rest rdf:nil
126 N940d4e65b73b4ae7a5177d49f372703f schema:name nlm_unique_id
127 schema:value 101251558
128 rdf:type schema:PropertyValue
129 Na5a5032a632043778296f333f8e747d1 schema:name readcube_id
130 schema:value 39dcfde2c02192883b8eb483d491df7a9a59de9f97fd96b641475b4ea422d08a
131 rdf:type schema:PropertyValue
132 Naee48dc221e8494aa079d4ad9cad7d80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Predictive Value of Tests
134 rdf:type schema:DefinedTerm
135 Nb056f182cbb24ab89933291122d7bc19 rdf:first sg:person.01103252766.82
136 rdf:rest N8a448165ede34fd0a7697b9231009556
137 Nb0e854f102e949888833145806fbbf20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Cell Proliferation
139 rdf:type schema:DefinedTerm
140 Nc0b9189d45a844b086e79c81ab1a9994 schema:name pubmed_id
141 schema:value 27113214
142 rdf:type schema:PropertyValue
143 Nc6c54c46922a4ca584daf94060fff1c7 schema:name doi
144 schema:value 10.1186/s13000-016-0491-5
145 rdf:type schema:PropertyValue
146 Nc95f9349a26d4e838498a00f1419d41f schema:issueNumber 1
147 rdf:type schema:PublicationIssue
148 Nc99800a965c44bf0b08b65242da93085 rdf:first sg:person.0637150121.38
149 rdf:rest N6c25b68220bc4eb88c80441f8e9f920f
150 Nca3a7d92a5974584b4971d07472f5dda schema:volumeNumber 11
151 rdf:type schema:PublicationVolume
152 Ncd3e7c7dad6d47469cb63aea004a16e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Aged
154 rdf:type schema:DefinedTerm
155 Nd0fc61569582451ead430803ee568412 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Female
157 rdf:type schema:DefinedTerm
158 Nd1ef705e52b94b06b99e2ed3ddc94cab rdf:first sg:person.01242362136.78
159 rdf:rest Ndc1b3fe027db433d926502494bef3ea7
160 Nd4aaadab747e443586028de542e64357 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Biomarkers, Tumor
162 rdf:type schema:DefinedTerm
163 Ndc1b3fe027db433d926502494bef3ea7 rdf:first sg:person.0630461205.19
164 rdf:rest Nc99800a965c44bf0b08b65242da93085
165 Ne92dd8face5c46278ee7471f874f8cce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Breast Neoplasms
167 rdf:type schema:DefinedTerm
168 Nef2b0261c5704f59814910f17e6682fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Up-Regulation
170 rdf:type schema:DefinedTerm
171 Nf11900d2e4cf47349ac7521bea77e96d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Immunohistochemistry
173 rdf:type schema:DefinedTerm
174 Nf39181cd81a049f6ac62397666657db6 schema:name dimensions_id
175 schema:value pub.1012145202
176 rdf:type schema:PropertyValue
177 Nf3e02413f93746f78ba95fa4972216c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Adult
179 rdf:type schema:DefinedTerm
180 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
181 schema:name Medical and Health Sciences
182 rdf:type schema:DefinedTerm
183 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
184 schema:name Oncology and Carcinogenesis
185 rdf:type schema:DefinedTerm
186 sg:journal.1327435 schema:issn 1746-1596
187 2364-4893
188 schema:name Diagnostic Pathology
189 rdf:type schema:Periodical
190 sg:person.01067625121.42 schema:affiliation https://www.grid.ac/institutes/grid.233520.5
191 schema:familyName Wang
192 schema:givenName Zhe
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067625121.42
194 rdf:type schema:Person
195 sg:person.01103252766.82 schema:affiliation https://www.grid.ac/institutes/grid.233520.5
196 schema:familyName Ma
197 schema:givenName Shirong
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103252766.82
199 rdf:type schema:Person
200 sg:person.01202060376.90 schema:affiliation https://www.grid.ac/institutes/grid.233520.5
201 schema:familyName Wang
202 schema:givenName Yingmei
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202060376.90
204 rdf:type schema:Person
205 sg:person.01242362136.78 schema:affiliation https://www.grid.ac/institutes/grid.233520.5
206 schema:familyName Guo
207 schema:givenName Shuangping
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242362136.78
209 rdf:type schema:Person
210 sg:person.0630461205.19 schema:affiliation https://www.grid.ac/institutes/grid.233520.5
211 schema:familyName Li
212 schema:givenName Xia
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630461205.19
214 rdf:type schema:Person
215 sg:person.0637150121.38 schema:affiliation https://www.grid.ac/institutes/grid.266813.8
216 schema:familyName Rohr
217 schema:givenName Joseph
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637150121.38
219 rdf:type schema:Person
220 sg:pub.10.1038/ncomms6987 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007923439
221 https://doi.org/10.1038/ncomms6987
222 rdf:type schema:CreativeWork
223 sg:pub.10.1038/onc.2008.433 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019798988
224 https://doi.org/10.1038/onc.2008.433
225 rdf:type schema:CreativeWork
226 sg:pub.10.1038/onc.2011.118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033534564
227 https://doi.org/10.1038/onc.2011.118
228 rdf:type schema:CreativeWork
229 sg:pub.10.1038/onc.2012.390 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011568592
230 https://doi.org/10.1038/onc.2012.390
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1002/cncr.22381 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036147682
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/j.humpath.2011.12.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017914229
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/j.molonc.2012.06.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011420580
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1073/pnas.1308953111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000483367
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1073/pnas.1933744100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006013665
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1080/00313020802563510 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045011485
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1093/annonc/mdu391 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035440462
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1093/emboj/cdg542 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029576413
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1097/pat.0b013e3283534bcb schema:sameAs https://app.dimensions.ai/details/publication/pub.1060343612
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1128/mcb.00426-13 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026714846
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1158/0008-5472.can-05-4300 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010802411
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1158/0008-5472.can-06-2384 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018316116
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1158/0008-5472.can-10-1199 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022542303
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1158/0008-5472.can-11-3546 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022967334
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1158/1078-0432.ccr-05-1533 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006433730
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1158/1078-0432.ccr-06-3045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048367977
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1200/jco.2005.01.5180 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046338079
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1200/jco.2009.25.6529 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016721540
267 rdf:type schema:CreativeWork
268 https://doi.org/10.2147/ott.s67673 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044115872
269 rdf:type schema:CreativeWork
270 https://doi.org/10.2174/1871520615666150129211901 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069219098
271 rdf:type schema:CreativeWork
272 https://doi.org/10.2217/epi.14.59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010854839
273 rdf:type schema:CreativeWork
274 https://doi.org/10.4161/cbt.27306 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072293046
275 rdf:type schema:CreativeWork
276 https://doi.org/10.4161/epi.24532 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042356293
277 rdf:type schema:CreativeWork
278 https://doi.org/10.5858/arpa.2013-0953-sa schema:sameAs https://app.dimensions.ai/details/publication/pub.1023063099
279 rdf:type schema:CreativeWork
280 https://www.grid.ac/institutes/grid.233520.5 schema:alternateName Fourth Military Medical University
281 schema:name Department of Pathology, Xi Jing Hospital, the Fourth Military Medical University, 710032, Xi’an, Shaan Xi Province, China
282 rdf:type schema:Organization
283 https://www.grid.ac/institutes/grid.266813.8 schema:alternateName University of Nebraska Medical Center
284 schema:name Department of Pathology and Microbiology, University of Nebraska Medical Center, 68105, Omaha, NE, USA
285 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...